Position in ABBV
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$2,450,470
+$389,318 QoQ
Shares Held
9,738
+2.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
#1,803
of 4,153 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Strategic Blueprint, LLC holds $25,782,970 across 8 Drug Manufacturers - General names. ABBV ranks #3 (9.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,696 | $16,427,394 | |
| 2 | JNJ |
Johnson & Johnson
|
12,796 | $3,249,800 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
9,738 | $2,450,470 | |
| 4 | MRK |
Merck & Co., Inc.
|
13,246 | $1,702,111 | |
| 5 | PFE |
Pfizer Inc
|
30,778 | $741,134 | |
| 6 | AMGN |
Amgen Inc
|
1,477 | $534,851 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,819 | $356,152 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,572 | $321,058 |
All Filings in ABBV
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,450,470 | 9,738 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $2,061,152 | 9,477 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $2,124,728 | 9,299 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $2,382,778 | 10,291 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $1,848,960 | 9,961 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $2,095,828 | 10,003 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $1,827,289 | 10,283 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $1,995,337 | 10,104 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $1,944,350 | 11,336 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $2,027,865 | 11,136 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $1,619,436 | 10,450 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $1,685,272 | 11,306 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $1,484,724 | 11,020 | Shares | Sole | 2023-10-18 | |
| 2023-03-31 | $1,744,782 | 10,948 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $1,638,078 | 10,136 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $1,336,597 | 9,959 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,401,720 | 9,152 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,450,073 | 8,945 | Shares | Sole | 2022-08-12 | |
| 2021-12-31 | $1,321,774 | 9,762 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $907,186 | 8,410 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,064,110 | 9,447 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $888,269 | 8,208 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $795,481 | 7,424 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $602,356 | 6,877 | Shares | Sole | 2020-10-27 | |
| No filing history on record for this holder in this stock. | ||||||